Merit Medical Systems (NASDAQ:MMSI) is a medical device company that develops, manufactures and markets disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in areas including cardiology, radiology, oncology, vascular intervention, gastroenterology and other specialty fields.
The company’s product portfolio includes devices for accessing the vasculature, controlling and managing fluids, performing biopsies, treating peripheral vascular disease, delivering embolic therapies, and supporting drainage and intervention procedures. Merit also provides products used in cardiac intervention, including devices and accessories for catheter-based procedures.
Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves hospitals, clinics and other healthcare providers in the United States and international markets. The company sells its products through a combination of direct sales personnel and distributors across a broad global geography.
Merit Medical was founded by Fred P. Lampropoulos, who has served as the company’s chairman and chief executive officer. The company has expanded its operations over time through internal product development and acquisitions intended to broaden its portfolio of minimally invasive medical technologies.
